345P The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

Autor: G. Liposits, H. Skuladottir, J. Ryg, S.B. Winther, S. Möller, E. Hofsli, C-H. Shah, L. Poulsen Oestergaard, A. Berglund, C. Qvortrup, P.J. Osterlund, J.S. Johansen, B. Glimelius, H. Sorbye, P. Pfeiffer

Publikováno v: Annals of Oncology. 33:S694

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4471e2e381741e76499acb64509693be
https://doi.org/10.1016/j.annonc.2022.07.483

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor): Phase I Trial

Autor: Anders Ullén, Fredrik Jäderling, Per Grybäck, Mads Agerbæk, Helle Pappot, Jeffrey Yachnin, C.-H. Shah, H. Von Der Maase, Karin Holmsten

Publikováno v: Shah, C H, Pappot, H, Agerbæk, M, Holmsten, K, Jäderling, F, Yachnin, J, Grybäck, P, von der Maase, H & Ullén, A 2019, ' Safety and Activity of Sorafenib in Addition to Vinflunine in Post-Platinum Metastatic Urothelial Carcinoma (Vinsor) : Phase I Trial ', Oncologist, vol. 24, no. 6, pp. 745-e213 . https://doi.org/10.1634/theoncologist.2018-0795
The Oncologist

Lessons Learned First trial to report safety and activity of the microtubule inhibitor vinflunine plus the tyrosine kinase inhibitor sorafenib in post-platinum metastatic urothelial cancer (mUC) patients. A recommended phase II dose was identified fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff3929a4c4a45f95a3a44374e26cc6eb
https://doi.org/10.1634/theoncologist.2018-0795

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P017 Vinflunine as second line chemotherapy for patients with metastatic urothelial cancer – A Nordic multi-center retrospective study

Autor: K. Holmsten, Anders Ullén, Helle Pappot, L.H. Dohn, C.-H. Shah, Niels Viggo Jensen

Publikováno v: European Urology Supplements. 12:136-137

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d33e0a41640a4dc48d471df17b710ee
https://doi.org/10.1016/s1569-9056(13)62345-3